nodes	percent_of_prediction	percent_of_DWPC	metapath
Nortriptyline—HTR2C—type 2 diabetes mellitus	0.0922	0.287	CbGaD
Nortriptyline—CYP2E1—type 2 diabetes mellitus	0.0731	0.228	CbGaD
Nortriptyline—CYP1A2—type 2 diabetes mellitus	0.0696	0.217	CbGaD
Nortriptyline—CYP3A4—type 2 diabetes mellitus	0.046	0.143	CbGaD
Nortriptyline—ALB—type 2 diabetes mellitus	0.0402	0.125	CbGaD
Nortriptyline—HTR6—Bromocriptine—type 2 diabetes mellitus	0.0216	0.0477	CbGbCtD
Nortriptyline—ORM1—Nateglinide—type 2 diabetes mellitus	0.02	0.0442	CbGbCtD
Nortriptyline—ADRA1D—Bromocriptine—type 2 diabetes mellitus	0.0189	0.0417	CbGbCtD
Nortriptyline—PTGS1—Chlorpropamide—type 2 diabetes mellitus	0.0149	0.0328	CbGbCtD
Nortriptyline—PTGS1—Pioglitazone—type 2 diabetes mellitus	0.0149	0.0328	CbGbCtD
Nortriptyline—ADRA1B—Bromocriptine—type 2 diabetes mellitus	0.0137	0.0304	CbGbCtD
Nortriptyline—PTGS1—Rosiglitazone—type 2 diabetes mellitus	0.0137	0.0303	CbGbCtD
Nortriptyline—ALB—Gliclazide—type 2 diabetes mellitus	0.0131	0.0289	CbGbCtD
Nortriptyline—HTR2C—Bromocriptine—type 2 diabetes mellitus	0.0125	0.0277	CbGbCtD
Nortriptyline—ALB—Repaglinide—type 2 diabetes mellitus	0.0123	0.0271	CbGbCtD
Nortriptyline—HTR1A—Bromocriptine—type 2 diabetes mellitus	0.0118	0.0261	CbGbCtD
Nortriptyline—HTR2A—Bromocriptine—type 2 diabetes mellitus	0.0113	0.025	CbGbCtD
Nortriptyline—PTGS1—Nateglinide—type 2 diabetes mellitus	0.0113	0.0249	CbGbCtD
Nortriptyline—ADRA1A—Bromocriptine—type 2 diabetes mellitus	0.0108	0.0239	CbGbCtD
Nortriptyline—PTGS1—Irbesartan—type 2 diabetes mellitus	0.0108	0.0239	CbGbCtD
Nortriptyline—DRD2—Bromocriptine—type 2 diabetes mellitus	0.0104	0.023	CbGbCtD
Nortriptyline—ALB—Rosiglitazone—type 2 diabetes mellitus	0.0103	0.0226	CbGbCtD
Nortriptyline—ALB—Valsartan—type 2 diabetes mellitus	0.00906	0.02	CbGbCtD
Nortriptyline—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.00847	0.0187	CbGbCtD
Nortriptyline—ALB—Nateglinide—type 2 diabetes mellitus	0.00842	0.0186	CbGbCtD
Nortriptyline—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.00828	0.0183	CbGbCtD
Nortriptyline—CYP2C9—Glipizide—type 2 diabetes mellitus	0.00758	0.0167	CbGbCtD
Nortriptyline—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.0072	0.0159	CbGbCtD
Nortriptyline—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.0072	0.0159	CbGbCtD
Nortriptyline—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.00704	0.0156	CbGbCtD
Nortriptyline—CYP3A5—Nateglinide—type 2 diabetes mellitus	0.00677	0.0149	CbGbCtD
Nortriptyline—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.00665	0.0147	CbGbCtD
Nortriptyline—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.00642	0.0142	CbGbCtD
Nortriptyline—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.00613	0.0135	CbGbCtD
Nortriptyline—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.00599	0.0132	CbGbCtD
Nortriptyline—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.00599	0.0132	CbGbCtD
Nortriptyline—ALB—Glyburide—type 2 diabetes mellitus	0.00569	0.0126	CbGbCtD
Nortriptyline—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.00553	0.0122	CbGbCtD
Nortriptyline—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.00548	0.0121	CbGbCtD
Nortriptyline—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0054	0.0119	CbGbCtD
Nortriptyline—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.00534	0.0118	CbGbCtD
Nortriptyline—ALB—Losartan—type 2 diabetes mellitus	0.0052	0.0115	CbGbCtD
Nortriptyline—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.00505	0.0112	CbGbCtD
Nortriptyline—CYP2C9—Valsartan—type 2 diabetes mellitus	0.00488	0.0108	CbGbCtD
Nortriptyline—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.00483	0.0107	CbGbCtD
Nortriptyline—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00482	0.0106	CbGbCtD
Nortriptyline—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.00457	0.0101	CbGbCtD
Nortriptyline—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.00454	0.01	CbGbCtD
Nortriptyline—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0044	0.00973	CbGbCtD
Nortriptyline—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.00435	0.00961	CbGbCtD
Nortriptyline—CYP3A5—Losartan—type 2 diabetes mellitus	0.00418	0.00923	CbGbCtD
Nortriptyline—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.00415	0.00916	CbGbCtD
Nortriptyline—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.00398	0.00879	CbGbCtD
Nortriptyline—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00385	0.0085	CbGbCtD
Nortriptyline—CYP2C19—Glyburide—type 2 diabetes mellitus	0.00369	0.00814	CbGbCtD
Nortriptyline—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00348	0.00769	CbGbCtD
Nortriptyline—CYP2C19—Losartan—type 2 diabetes mellitus	0.00337	0.00745	CbGbCtD
Nortriptyline—CYP1A2—Losartan—type 2 diabetes mellitus	0.00311	0.00687	CbGbCtD
Nortriptyline—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00307	0.00677	CbGbCtD
Nortriptyline—CYP2C9—Losartan—type 2 diabetes mellitus	0.0028	0.00619	CbGbCtD
Nortriptyline—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00264	0.00583	CbGbCtD
Nortriptyline—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00253	0.00559	CbGbCtD
Nortriptyline—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00253	0.00559	CbGbCtD
Nortriptyline—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00239	0.00528	CbGbCtD
Nortriptyline—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00178	0.00394	CbGbCtD
Nortriptyline—SLC6A2—sympathetic nervous system—type 2 diabetes mellitus	0.00174	0.1	CbGeAlD
Nortriptyline—HTR2A—arteriole—type 2 diabetes mellitus	0.00164	0.0946	CbGeAlD
Nortriptyline—CYP3A4—Losartan—type 2 diabetes mellitus	0.00163	0.0036	CbGbCtD
Nortriptyline—SLC6A2—autonomic nervous system—type 2 diabetes mellitus	0.00117	0.0675	CbGeAlD
Nortriptyline—HTR2A—sympathetic nervous system—type 2 diabetes mellitus	0.00104	0.0603	CbGeAlD
Nortriptyline—HTR2A—autonomic nervous system—type 2 diabetes mellitus	0.000701	0.0405	CbGeAlD
Nortriptyline—SLC6A2—nerve—type 2 diabetes mellitus	0.000656	0.0379	CbGeAlD
Nortriptyline—HTR2A—hindlimb—type 2 diabetes mellitus	0.000649	0.0375	CbGeAlD
Nortriptyline—DRD2—nerve—type 2 diabetes mellitus	0.000598	0.0346	CbGeAlD
Nortriptyline—HTR2A—peripheral nervous system—type 2 diabetes mellitus	0.000506	0.0292	CbGeAlD
Nortriptyline—PTGS1—artery—type 2 diabetes mellitus	0.000441	0.0255	CbGeAlD
Nortriptyline—HTR2A—artery—type 2 diabetes mellitus	0.000398	0.023	CbGeAlD
Nortriptyline—HTR2A—nerve—type 2 diabetes mellitus	0.000395	0.0228	CbGeAlD
Nortriptyline—PTGS1—endothelium—type 2 diabetes mellitus	0.000372	0.0215	CbGeAlD
Nortriptyline—ADRA1B—kidney—type 2 diabetes mellitus	0.000372	0.0215	CbGeAlD
Nortriptyline—HTR2A—endothelium—type 2 diabetes mellitus	0.000336	0.0194	CbGeAlD
Nortriptyline—CHRM2—cardiovascular system—type 2 diabetes mellitus	0.000286	0.0165	CbGeAlD
Nortriptyline—CHRM1—cardiovascular system—type 2 diabetes mellitus	0.00026	0.015	CbGeAlD
Nortriptyline—DRD2—retina—type 2 diabetes mellitus	0.000248	0.0143	CbGeAlD
Nortriptyline—CYP3A5—islet of Langerhans—type 2 diabetes mellitus	0.000236	0.0136	CbGeAlD
Nortriptyline—HTR1A—cardiovascular system—type 2 diabetes mellitus	0.000232	0.0134	CbGeAlD
Nortriptyline—CHRM3—kidney—type 2 diabetes mellitus	0.000228	0.0132	CbGeAlD
Nortriptyline—ADRA1A—cardiovascular system—type 2 diabetes mellitus	0.000214	0.0124	CbGeAlD
Nortriptyline—CHRM3—adipose tissue—type 2 diabetes mellitus	0.000205	0.0119	CbGeAlD
Nortriptyline—CYP3A5—nephron tubule—type 2 diabetes mellitus	0.00019	0.011	CbGeAlD
Nortriptyline—ORM1—liver—type 2 diabetes mellitus	0.00019	0.011	CbGeAlD
Nortriptyline—ADRA1A—adipose tissue—type 2 diabetes mellitus	0.000189	0.0109	CbGeAlD
Nortriptyline—CYP2E1—nephron tubule—type 2 diabetes mellitus	0.000177	0.0102	CbGeAlD
Nortriptyline—CYP2C9—cardiovascular system—type 2 diabetes mellitus	0.000168	0.0097	CbGeAlD
Nortriptyline—CYP3A5—kidney—type 2 diabetes mellitus	0.000167	0.00964	CbGeAlD
Nortriptyline—ALB—liver—type 2 diabetes mellitus	0.000166	0.00961	CbGeAlD
Nortriptyline—CYP3A5—pancreas—type 2 diabetes mellitus	0.000166	0.00958	CbGeAlD
Nortriptyline—HTR2A—retina—type 2 diabetes mellitus	0.000163	0.00944	CbGeAlD
Nortriptyline—CYP3A5—cortex of kidney—type 2 diabetes mellitus	0.000162	0.00939	CbGeAlD
Nortriptyline—CYP2E1—cardiovascular system—type 2 diabetes mellitus	0.000159	0.00919	CbGeAlD
Nortriptyline—CYP2E1—kidney—type 2 diabetes mellitus	0.000156	0.00899	CbGeAlD
Nortriptyline—PTGS1—cardiovascular system—type 2 diabetes mellitus	0.000153	0.00885	CbGeAlD
Nortriptyline—CYP2E1—cortex of kidney—type 2 diabetes mellitus	0.000152	0.00876	CbGeAlD
Nortriptyline—CYP3A5—adipose tissue—type 2 diabetes mellitus	0.00015	0.00869	CbGeAlD
Nortriptyline—Epinastine—ADRA2A—type 2 diabetes mellitus	0.00015	0.0553	CrCbGaD
Nortriptyline—PTGS1—kidney—type 2 diabetes mellitus	0.00015	0.00866	CbGeAlD
Nortriptyline—HRH1—adipose tissue—type 2 diabetes mellitus	0.000146	0.00843	CbGeAlD
Nortriptyline—HTR2A—cardiovascular system—type 2 diabetes mellitus	0.000138	0.00799	CbGeAlD
Nortriptyline—HTR2A—kidney—type 2 diabetes mellitus	0.000135	0.00782	CbGeAlD
Nortriptyline—PTGS1—adipose tissue—type 2 diabetes mellitus	0.000135	0.00781	CbGeAlD
Nortriptyline—CYP2C19—liver—type 2 diabetes mellitus	0.000134	0.00774	CbGeAlD
Nortriptyline—ADRA1A—liver—type 2 diabetes mellitus	0.000132	0.00764	CbGeAlD
Nortriptyline—CYP3A4—kidney—type 2 diabetes mellitus	0.000125	0.00724	CbGeAlD
Nortriptyline—CYP2D6—kidney—type 2 diabetes mellitus	0.000123	0.00712	CbGeAlD
Nortriptyline—Azatadine—CYP3A4—type 2 diabetes mellitus	0.000119	0.044	CrCbGaD
Nortriptyline—Maprotiline—HTR2C—type 2 diabetes mellitus	0.000119	0.0438	CrCbGaD
Nortriptyline—CYP1A2—liver—type 2 diabetes mellitus	0.000109	0.00632	CbGeAlD
Nortriptyline—Cyproheptadine—HTR2C—type 2 diabetes mellitus	0.000105	0.0389	CrCbGaD
Nortriptyline—CYP3A5—liver—type 2 diabetes mellitus	0.000105	0.00609	CbGeAlD
Nortriptyline—Cyclobenzaprine—CYP1A2—type 2 diabetes mellitus	0.000105	0.0387	CrCbGaD
Nortriptyline—CYP2C9—liver—type 2 diabetes mellitus	0.000104	0.006	CbGeAlD
Nortriptyline—CYP2E1—liver—type 2 diabetes mellitus	9.84e-05	0.00568	CbGeAlD
Nortriptyline—Maprotiline—CYP1A2—type 2 diabetes mellitus	8.97e-05	0.0331	CrCbGaD
Nortriptyline—Paraesthesia—Gliclazide—type 2 diabetes mellitus	8.83e-05	0.000736	CcSEcCtD
Nortriptyline—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	8.83e-05	0.000735	CcSEcCtD
Nortriptyline—Hepatitis—Ramipril—type 2 diabetes mellitus	8.82e-05	0.000735	CcSEcCtD
Nortriptyline—Tension—Losartan—type 2 diabetes mellitus	8.78e-05	0.000732	CcSEcCtD
Nortriptyline—Dizziness—Glimepiride—type 2 diabetes mellitus	8.78e-05	0.000731	CcSEcCtD
Nortriptyline—Dysgeusia—Losartan—type 2 diabetes mellitus	8.77e-05	0.00073	CcSEcCtD
Nortriptyline—Dizziness—Sitagliptin—type 2 diabetes mellitus	8.75e-05	0.000729	CcSEcCtD
Nortriptyline—Agitation—Irbesartan—type 2 diabetes mellitus	8.74e-05	0.000728	CcSEcCtD
Nortriptyline—Somnolence—Gliclazide—type 2 diabetes mellitus	8.74e-05	0.000728	CcSEcCtD
Nortriptyline—Hypertension—Metformin—type 2 diabetes mellitus	8.7e-05	0.000725	CcSEcCtD
Nortriptyline—Urticaria—Glyburide—type 2 diabetes mellitus	8.7e-05	0.000725	CcSEcCtD
Nortriptyline—Nervousness—Losartan—type 2 diabetes mellitus	8.69e-05	0.000724	CcSEcCtD
Nortriptyline—Oedema peripheral—Ramipril—type 2 diabetes mellitus	8.69e-05	0.000724	CcSEcCtD
Nortriptyline—Mianserin—ADRA2A—type 2 diabetes mellitus	8.68e-05	0.032	CrCbGaD
Nortriptyline—Abdominal pain—Glyburide—type 2 diabetes mellitus	8.66e-05	0.000721	CcSEcCtD
Nortriptyline—Dyspepsia—Gliclazide—type 2 diabetes mellitus	8.65e-05	0.000721	CcSEcCtD
Nortriptyline—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	8.63e-05	0.000719	CcSEcCtD
Nortriptyline—Anorexia—Valsartan—type 2 diabetes mellitus	8.61e-05	0.000717	CcSEcCtD
Nortriptyline—Asthenia—Bromocriptine—type 2 diabetes mellitus	8.59e-05	0.000716	CcSEcCtD
Nortriptyline—Malaise—Irbesartan—type 2 diabetes mellitus	8.58e-05	0.000715	CcSEcCtD
Nortriptyline—HTR2A—liver—type 2 diabetes mellitus	8.55e-05	0.00494	CbGeAlD
Nortriptyline—Headache—Pioglitazone—type 2 diabetes mellitus	8.54e-05	0.000711	CcSEcCtD
Nortriptyline—Syncope—Irbesartan—type 2 diabetes mellitus	8.53e-05	0.000711	CcSEcCtD
Nortriptyline—Leukopenia—Irbesartan—type 2 diabetes mellitus	8.51e-05	0.000709	CcSEcCtD
Nortriptyline—Discomfort—Metformin—type 2 diabetes mellitus	8.48e-05	0.000706	CcSEcCtD
Nortriptyline—Fatigue—Gliclazide—type 2 diabetes mellitus	8.48e-05	0.000706	CcSEcCtD
Nortriptyline—Nausea—Glipizide—type 2 diabetes mellitus	8.45e-05	0.000704	CcSEcCtD
Nortriptyline—Vomiting—Glimepiride—type 2 diabetes mellitus	8.44e-05	0.000703	CcSEcCtD
Nortriptyline—Hypotension—Valsartan—type 2 diabetes mellitus	8.44e-05	0.000703	CcSEcCtD
Nortriptyline—Vision blurred—Losartan—type 2 diabetes mellitus	8.44e-05	0.000703	CcSEcCtD
Nortriptyline—Vomiting—Sitagliptin—type 2 diabetes mellitus	8.41e-05	0.000701	CcSEcCtD
Nortriptyline—Constipation—Gliclazide—type 2 diabetes mellitus	8.41e-05	0.0007	CcSEcCtD
Nortriptyline—Tremor—Losartan—type 2 diabetes mellitus	8.39e-05	0.000699	CcSEcCtD
Nortriptyline—Rash—Glimepiride—type 2 diabetes mellitus	8.37e-05	0.000697	CcSEcCtD
Nortriptyline—Dermatitis—Glimepiride—type 2 diabetes mellitus	8.36e-05	0.000697	CcSEcCtD
Nortriptyline—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	8.36e-05	0.000697	CcSEcCtD
Nortriptyline—Rash—Sitagliptin—type 2 diabetes mellitus	8.34e-05	0.000695	CcSEcCtD
Nortriptyline—Dermatitis—Sitagliptin—type 2 diabetes mellitus	8.34e-05	0.000695	CcSEcCtD
Nortriptyline—Headache—Glimepiride—type 2 diabetes mellitus	8.32e-05	0.000693	CcSEcCtD
Nortriptyline—Ill-defined disorder—Losartan—type 2 diabetes mellitus	8.31e-05	0.000692	CcSEcCtD
Nortriptyline—Headache—Sitagliptin—type 2 diabetes mellitus	8.29e-05	0.000691	CcSEcCtD
Nortriptyline—Olopatadine—CYP3A4—type 2 diabetes mellitus	8.27e-05	0.0305	CrCbGaD
Nortriptyline—Agitation—Losartan—type 2 diabetes mellitus	8.23e-05	0.000685	CcSEcCtD
Nortriptyline—Oedema—Metformin—type 2 diabetes mellitus	8.23e-05	0.000685	CcSEcCtD
Nortriptyline—Tinnitus—Ramipril—type 2 diabetes mellitus	8.22e-05	0.000685	CcSEcCtD
Nortriptyline—Hypertension—Irbesartan—type 2 diabetes mellitus	8.21e-05	0.000684	CcSEcCtD
Nortriptyline—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	8.19e-05	0.000683	CcSEcCtD
Nortriptyline—Flushing—Ramipril—type 2 diabetes mellitus	8.18e-05	0.000682	CcSEcCtD
Nortriptyline—Atomoxetine—HTR2C—type 2 diabetes mellitus	8.18e-05	0.0301	CrCbGaD
Nortriptyline—Insomnia—Valsartan—type 2 diabetes mellitus	8.17e-05	0.000681	CcSEcCtD
Nortriptyline—Paraesthesia—Valsartan—type 2 diabetes mellitus	8.11e-05	0.000676	CcSEcCtD
Nortriptyline—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	8.1e-05	0.000675	CcSEcCtD
Nortriptyline—Shock—Metformin—type 2 diabetes mellitus	8.09e-05	0.000674	CcSEcCtD
Nortriptyline—Insomnia—Orlistat—type 2 diabetes mellitus	8.07e-05	0.000673	CcSEcCtD
Nortriptyline—Malaise—Losartan—type 2 diabetes mellitus	8.07e-05	0.000673	CcSEcCtD
Nortriptyline—Anxiety—Irbesartan—type 2 diabetes mellitus	8.07e-05	0.000672	CcSEcCtD
Nortriptyline—Hypersensitivity—Glyburide—type 2 diabetes mellitus	8.07e-05	0.000672	CcSEcCtD
Nortriptyline—Thrombocytopenia—Metformin—type 2 diabetes mellitus	8.05e-05	0.000671	CcSEcCtD
Nortriptyline—Somnolence—Valsartan—type 2 diabetes mellitus	8.03e-05	0.000669	CcSEcCtD
Nortriptyline—Syncope—Losartan—type 2 diabetes mellitus	8.03e-05	0.000669	CcSEcCtD
Nortriptyline—Paraesthesia—Orlistat—type 2 diabetes mellitus	8.01e-05	0.000668	CcSEcCtD
Nortriptyline—Leukopenia—Losartan—type 2 diabetes mellitus	8.01e-05	0.000668	CcSEcCtD
Nortriptyline—Discomfort—Irbesartan—type 2 diabetes mellitus	8e-05	0.000667	CcSEcCtD
Nortriptyline—Mianserin—HTR2C—type 2 diabetes mellitus	7.99e-05	0.0295	CrCbGaD
Nortriptyline—Hyperhidrosis—Metformin—type 2 diabetes mellitus	7.95e-05	0.000663	CcSEcCtD
Nortriptyline—Dyspepsia—Valsartan—type 2 diabetes mellitus	7.95e-05	0.000662	CcSEcCtD
Nortriptyline—Clomipramine—ADRA2A—type 2 diabetes mellitus	7.94e-05	0.0293	CrCbGaD
Nortriptyline—Dizziness—Bromocriptine—type 2 diabetes mellitus	7.92e-05	0.00066	CcSEcCtD
Nortriptyline—Dry mouth—Irbesartan—type 2 diabetes mellitus	7.92e-05	0.00066	CcSEcCtD
Nortriptyline—CYP3A4—liver—type 2 diabetes mellitus	7.91e-05	0.00457	CbGeAlD
Nortriptyline—Palpitations—Losartan—type 2 diabetes mellitus	7.91e-05	0.000659	CcSEcCtD
Nortriptyline—Nausea—Glimepiride—type 2 diabetes mellitus	7.89e-05	0.000657	CcSEcCtD
Nortriptyline—Arrhythmia—Ramipril—type 2 diabetes mellitus	7.88e-05	0.000656	CcSEcCtD
Nortriptyline—Loss of consciousness—Losartan—type 2 diabetes mellitus	7.87e-05	0.000655	CcSEcCtD
Nortriptyline—Nausea—Sitagliptin—type 2 diabetes mellitus	7.86e-05	0.000655	CcSEcCtD
Nortriptyline—Dyspepsia—Orlistat—type 2 diabetes mellitus	7.86e-05	0.000655	CcSEcCtD
Nortriptyline—Asthenia—Glyburide—type 2 diabetes mellitus	7.86e-05	0.000655	CcSEcCtD
Nortriptyline—Decreased appetite—Valsartan—type 2 diabetes mellitus	7.85e-05	0.000654	CcSEcCtD
Nortriptyline—Anorexia—Metformin—type 2 diabetes mellitus	7.84e-05	0.000653	CcSEcCtD
Nortriptyline—Urticaria—Gliclazide—type 2 diabetes mellitus	7.81e-05	0.000651	CcSEcCtD
Nortriptyline—Alopecia—Ramipril—type 2 diabetes mellitus	7.79e-05	0.000649	CcSEcCtD
Nortriptyline—Fatigue—Valsartan—type 2 diabetes mellitus	7.79e-05	0.000649	CcSEcCtD
Nortriptyline—CYP2D6—liver—type 2 diabetes mellitus	7.79e-05	0.0045	CbGeAlD
Nortriptyline—Abdominal pain—Gliclazide—type 2 diabetes mellitus	7.77e-05	0.000648	CcSEcCtD
Nortriptyline—Body temperature increased—Gliclazide—type 2 diabetes mellitus	7.77e-05	0.000648	CcSEcCtD
Nortriptyline—Oedema—Irbesartan—type 2 diabetes mellitus	7.76e-05	0.000647	CcSEcCtD
Nortriptyline—Decreased appetite—Orlistat—type 2 diabetes mellitus	7.76e-05	0.000646	CcSEcCtD
Nortriptyline—Pruritus—Glyburide—type 2 diabetes mellitus	7.75e-05	0.000645	CcSEcCtD
Nortriptyline—Constipation—Valsartan—type 2 diabetes mellitus	7.72e-05	0.000644	CcSEcCtD
Nortriptyline—Fatigue—Orlistat—type 2 diabetes mellitus	7.7e-05	0.000641	CcSEcCtD
Nortriptyline—Hypotension—Metformin—type 2 diabetes mellitus	7.69e-05	0.00064	CcSEcCtD
Nortriptyline—Shock—Irbesartan—type 2 diabetes mellitus	7.64e-05	0.000636	CcSEcCtD
Nortriptyline—Vomiting—Bromocriptine—type 2 diabetes mellitus	7.62e-05	0.000634	CcSEcCtD
Nortriptyline—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	7.6e-05	0.000633	CcSEcCtD
Nortriptyline—Anxiety—Losartan—type 2 diabetes mellitus	7.59e-05	0.000633	CcSEcCtD
Nortriptyline—Tachycardia—Irbesartan—type 2 diabetes mellitus	7.58e-05	0.000631	CcSEcCtD
Nortriptyline—Rash—Bromocriptine—type 2 diabetes mellitus	7.55e-05	0.000629	CcSEcCtD
Nortriptyline—Dermatitis—Bromocriptine—type 2 diabetes mellitus	7.54e-05	0.000629	CcSEcCtD
Nortriptyline—Tension—Ramipril—type 2 diabetes mellitus	7.53e-05	0.000628	CcSEcCtD
Nortriptyline—Discomfort—Losartan—type 2 diabetes mellitus	7.53e-05	0.000627	CcSEcCtD
Nortriptyline—Dysgeusia—Ramipril—type 2 diabetes mellitus	7.52e-05	0.000626	CcSEcCtD
Nortriptyline—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	7.5e-05	0.000625	CcSEcCtD
Nortriptyline—Headache—Bromocriptine—type 2 diabetes mellitus	7.5e-05	0.000625	CcSEcCtD
Nortriptyline—Diarrhoea—Glyburide—type 2 diabetes mellitus	7.49e-05	0.000624	CcSEcCtD
Nortriptyline—Nervousness—Ramipril—type 2 diabetes mellitus	7.45e-05	0.000621	CcSEcCtD
Nortriptyline—Dry mouth—Losartan—type 2 diabetes mellitus	7.45e-05	0.000621	CcSEcCtD
Nortriptyline—Anorexia—Irbesartan—type 2 diabetes mellitus	7.4e-05	0.000616	CcSEcCtD
Nortriptyline—Paraesthesia—Metformin—type 2 diabetes mellitus	7.39e-05	0.000615	CcSEcCtD
Nortriptyline—Confusional state—Losartan—type 2 diabetes mellitus	7.37e-05	0.000614	CcSEcCtD
Nortriptyline—Feeling abnormal—Orlistat—type 2 diabetes mellitus	7.36e-05	0.000613	CcSEcCtD
Nortriptyline—Somnolence—Metformin—type 2 diabetes mellitus	7.31e-05	0.000609	CcSEcCtD
Nortriptyline—Clomipramine—HTR2C—type 2 diabetes mellitus	7.31e-05	0.0269	CrCbGaD
Nortriptyline—Trimipramine—ADRA2A—type 2 diabetes mellitus	7.31e-05	0.0269	CrCbGaD
Nortriptyline—Oedema—Losartan—type 2 diabetes mellitus	7.31e-05	0.000609	CcSEcCtD
Nortriptyline—Chlorprothixene—HTR2C—type 2 diabetes mellitus	7.28e-05	0.0268	CrCbGaD
Nortriptyline—Hypotension—Irbesartan—type 2 diabetes mellitus	7.25e-05	0.000604	CcSEcCtD
Nortriptyline—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	7.24e-05	0.000604	CcSEcCtD
Nortriptyline—Dyspepsia—Metformin—type 2 diabetes mellitus	7.24e-05	0.000603	CcSEcCtD
Nortriptyline—Tremor—Ramipril—type 2 diabetes mellitus	7.19e-05	0.000599	CcSEcCtD
Nortriptyline—Shock—Losartan—type 2 diabetes mellitus	7.19e-05	0.000599	CcSEcCtD
Nortriptyline—Urticaria—Valsartan—type 2 diabetes mellitus	7.18e-05	0.000598	CcSEcCtD
Nortriptyline—Thrombocytopenia—Losartan—type 2 diabetes mellitus	7.15e-05	0.000596	CcSEcCtD
Nortriptyline—Decreased appetite—Metformin—type 2 diabetes mellitus	7.15e-05	0.000596	CcSEcCtD
Nortriptyline—Abdominal pain—Valsartan—type 2 diabetes mellitus	7.14e-05	0.000595	CcSEcCtD
Nortriptyline—Tachycardia—Losartan—type 2 diabetes mellitus	7.13e-05	0.000594	CcSEcCtD
Nortriptyline—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	7.12e-05	0.000593	CcSEcCtD
Nortriptyline—Nausea—Bromocriptine—type 2 diabetes mellitus	7.11e-05	0.000593	CcSEcCtD
Nortriptyline—Fatigue—Metformin—type 2 diabetes mellitus	7.09e-05	0.000591	CcSEcCtD
Nortriptyline—Urticaria—Orlistat—type 2 diabetes mellitus	7.09e-05	0.000591	CcSEcCtD
Nortriptyline—Hyperhidrosis—Losartan—type 2 diabetes mellitus	7.06e-05	0.000588	CcSEcCtD
Nortriptyline—Abdominal pain—Orlistat—type 2 diabetes mellitus	7.06e-05	0.000588	CcSEcCtD
Nortriptyline—Body temperature increased—Orlistat—type 2 diabetes mellitus	7.06e-05	0.000588	CcSEcCtD
Nortriptyline—Asthenia—Gliclazide—type 2 diabetes mellitus	7.05e-05	0.000588	CcSEcCtD
Nortriptyline—Agitation—Ramipril—type 2 diabetes mellitus	7.05e-05	0.000588	CcSEcCtD
Nortriptyline—Constipation—Metformin—type 2 diabetes mellitus	7.03e-05	0.000586	CcSEcCtD
Nortriptyline—Paraesthesia—Irbesartan—type 2 diabetes mellitus	6.97e-05	0.000581	CcSEcCtD
Nortriptyline—Doxepin—ADRA2A—type 2 diabetes mellitus	6.96e-05	0.0257	CrCbGaD
Nortriptyline—Anorexia—Losartan—type 2 diabetes mellitus	6.96e-05	0.00058	CcSEcCtD
Nortriptyline—Vomiting—Glyburide—type 2 diabetes mellitus	6.96e-05	0.00058	CcSEcCtD
Nortriptyline—Pruritus—Gliclazide—type 2 diabetes mellitus	6.96e-05	0.00058	CcSEcCtD
Nortriptyline—Cyclobenzaprine—CYP3A4—type 2 diabetes mellitus	6.95e-05	0.0256	CrCbGaD
Nortriptyline—Malaise—Ramipril—type 2 diabetes mellitus	6.92e-05	0.000577	CcSEcCtD
Nortriptyline—Rash—Glyburide—type 2 diabetes mellitus	6.9e-05	0.000575	CcSEcCtD
Nortriptyline—Epinastine—CYP3A4—type 2 diabetes mellitus	6.9e-05	0.0254	CrCbGaD
Nortriptyline—Somnolence—Irbesartan—type 2 diabetes mellitus	6.9e-05	0.000575	CcSEcCtD
Nortriptyline—Dermatitis—Glyburide—type 2 diabetes mellitus	6.9e-05	0.000575	CcSEcCtD
Nortriptyline—Syncope—Ramipril—type 2 diabetes mellitus	6.88e-05	0.000573	CcSEcCtD
Nortriptyline—Leukopenia—Ramipril—type 2 diabetes mellitus	6.87e-05	0.000572	CcSEcCtD
Nortriptyline—Headache—Glyburide—type 2 diabetes mellitus	6.86e-05	0.000571	CcSEcCtD
Nortriptyline—Dyspepsia—Irbesartan—type 2 diabetes mellitus	6.83e-05	0.000569	CcSEcCtD
Nortriptyline—Hypotension—Losartan—type 2 diabetes mellitus	6.83e-05	0.000569	CcSEcCtD
Nortriptyline—Palpitations—Ramipril—type 2 diabetes mellitus	6.78e-05	0.000565	CcSEcCtD
Nortriptyline—Feeling abnormal—Metformin—type 2 diabetes mellitus	6.78e-05	0.000565	CcSEcCtD
Nortriptyline—Decreased appetite—Irbesartan—type 2 diabetes mellitus	6.75e-05	0.000562	CcSEcCtD
Nortriptyline—Loss of consciousness—Ramipril—type 2 diabetes mellitus	6.75e-05	0.000562	CcSEcCtD
Nortriptyline—Trimipramine—HTR2C—type 2 diabetes mellitus	6.73e-05	0.0248	CrCbGaD
Nortriptyline—Diarrhoea—Gliclazide—type 2 diabetes mellitus	6.73e-05	0.00056	CcSEcCtD
Nortriptyline—Fatigue—Irbesartan—type 2 diabetes mellitus	6.69e-05	0.000558	CcSEcCtD
Nortriptyline—Hypersensitivity—Valsartan—type 2 diabetes mellitus	6.65e-05	0.000554	CcSEcCtD
Nortriptyline—Convulsion—Ramipril—type 2 diabetes mellitus	6.65e-05	0.000554	CcSEcCtD
Nortriptyline—Constipation—Irbesartan—type 2 diabetes mellitus	6.64e-05	0.000553	CcSEcCtD
Nortriptyline—Insomnia—Losartan—type 2 diabetes mellitus	6.61e-05	0.000551	CcSEcCtD
Nortriptyline—Hypersensitivity—Orlistat—type 2 diabetes mellitus	6.58e-05	0.000548	CcSEcCtD
Nortriptyline—Paraesthesia—Losartan—type 2 diabetes mellitus	6.56e-05	0.000547	CcSEcCtD
Nortriptyline—Urticaria—Metformin—type 2 diabetes mellitus	6.53e-05	0.000544	CcSEcCtD
Nortriptyline—Anxiety—Ramipril—type 2 diabetes mellitus	6.51e-05	0.000543	CcSEcCtD
Nortriptyline—Nausea—Glyburide—type 2 diabetes mellitus	6.5e-05	0.000542	CcSEcCtD
Nortriptyline—Abdominal pain—Metformin—type 2 diabetes mellitus	6.5e-05	0.000542	CcSEcCtD
Nortriptyline—Dizziness—Gliclazide—type 2 diabetes mellitus	6.5e-05	0.000542	CcSEcCtD
Nortriptyline—Somnolence—Losartan—type 2 diabetes mellitus	6.49e-05	0.000541	CcSEcCtD
Nortriptyline—Asthenia—Valsartan—type 2 diabetes mellitus	6.48e-05	0.00054	CcSEcCtD
Nortriptyline—Discomfort—Ramipril—type 2 diabetes mellitus	6.46e-05	0.000538	CcSEcCtD
Nortriptyline—Dyspepsia—Losartan—type 2 diabetes mellitus	6.43e-05	0.000536	CcSEcCtD
Nortriptyline—Doxepin—HTR2C—type 2 diabetes mellitus	6.41e-05	0.0236	CrCbGaD
Nortriptyline—Asthenia—Orlistat—type 2 diabetes mellitus	6.4e-05	0.000534	CcSEcCtD
Nortriptyline—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	6.4e-05	0.000533	CcSEcCtD
Nortriptyline—Pruritus—Valsartan—type 2 diabetes mellitus	6.39e-05	0.000532	CcSEcCtD
Nortriptyline—Dry mouth—Ramipril—type 2 diabetes mellitus	6.39e-05	0.000532	CcSEcCtD
Nortriptyline—Oxcarbazepine—CYP3A4—type 2 diabetes mellitus	6.36e-05	0.0234	CrCbGaD
Nortriptyline—Decreased appetite—Losartan—type 2 diabetes mellitus	6.35e-05	0.000529	CcSEcCtD
Nortriptyline—Confusional state—Ramipril—type 2 diabetes mellitus	6.32e-05	0.000526	CcSEcCtD
Nortriptyline—Pruritus—Orlistat—type 2 diabetes mellitus	6.31e-05	0.000526	CcSEcCtD
Nortriptyline—Fatigue—Losartan—type 2 diabetes mellitus	6.3e-05	0.000525	CcSEcCtD
Nortriptyline—Oedema—Ramipril—type 2 diabetes mellitus	6.26e-05	0.000522	CcSEcCtD
Nortriptyline—Vomiting—Gliclazide—type 2 diabetes mellitus	6.25e-05	0.000521	CcSEcCtD
Nortriptyline—Constipation—Losartan—type 2 diabetes mellitus	6.25e-05	0.00052	CcSEcCtD
Nortriptyline—Rash—Gliclazide—type 2 diabetes mellitus	6.2e-05	0.000516	CcSEcCtD
Nortriptyline—Dermatitis—Gliclazide—type 2 diabetes mellitus	6.19e-05	0.000516	CcSEcCtD
Nortriptyline—Diarrhoea—Valsartan—type 2 diabetes mellitus	6.18e-05	0.000515	CcSEcCtD
Nortriptyline—Urticaria—Irbesartan—type 2 diabetes mellitus	6.17e-05	0.000514	CcSEcCtD
Nortriptyline—Shock—Ramipril—type 2 diabetes mellitus	6.16e-05	0.000513	CcSEcCtD
Nortriptyline—Headache—Gliclazide—type 2 diabetes mellitus	6.16e-05	0.000513	CcSEcCtD
Nortriptyline—Abdominal pain—Irbesartan—type 2 diabetes mellitus	6.14e-05	0.000511	CcSEcCtD
Nortriptyline—Body temperature increased—Irbesartan—type 2 diabetes mellitus	6.14e-05	0.000511	CcSEcCtD
Nortriptyline—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	6.13e-05	0.000511	CcSEcCtD
Nortriptyline—Tachycardia—Ramipril—type 2 diabetes mellitus	6.11e-05	0.000509	CcSEcCtD
Nortriptyline—Diarrhoea—Orlistat—type 2 diabetes mellitus	6.11e-05	0.000509	CcSEcCtD
Nortriptyline—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	6.06e-05	0.000505	CcSEcCtD
Nortriptyline—Mianserin—CYP1A2—type 2 diabetes mellitus	6.03e-05	0.0222	CrCbGaD
Nortriptyline—Feeling abnormal—Losartan—type 2 diabetes mellitus	6.02e-05	0.000502	CcSEcCtD
Nortriptyline—Dizziness—Valsartan—type 2 diabetes mellitus	5.97e-05	0.000498	CcSEcCtD
Nortriptyline—Anorexia—Ramipril—type 2 diabetes mellitus	5.97e-05	0.000497	CcSEcCtD
Nortriptyline—Dizziness—Orlistat—type 2 diabetes mellitus	5.9e-05	0.000492	CcSEcCtD
Nortriptyline—Asthenia—Metformin—type 2 diabetes mellitus	5.9e-05	0.000492	CcSEcCtD
Nortriptyline—Desipramine—HTR2C—type 2 diabetes mellitus	5.88e-05	0.0217	CrCbGaD
Nortriptyline—Hypotension—Ramipril—type 2 diabetes mellitus	5.85e-05	0.000488	CcSEcCtD
Nortriptyline—Nausea—Gliclazide—type 2 diabetes mellitus	5.84e-05	0.000487	CcSEcCtD
Nortriptyline—Pruritus—Metformin—type 2 diabetes mellitus	5.82e-05	0.000485	CcSEcCtD
Nortriptyline—Urticaria—Losartan—type 2 diabetes mellitus	5.8e-05	0.000484	CcSEcCtD
Nortriptyline—Body temperature increased—Losartan—type 2 diabetes mellitus	5.78e-05	0.000481	CcSEcCtD
Nortriptyline—Abdominal pain—Losartan—type 2 diabetes mellitus	5.78e-05	0.000481	CcSEcCtD
Nortriptyline—Vomiting—Valsartan—type 2 diabetes mellitus	5.74e-05	0.000479	CcSEcCtD
Nortriptyline—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	5.72e-05	0.000477	CcSEcCtD
Nortriptyline—Rash—Valsartan—type 2 diabetes mellitus	5.7e-05	0.000475	CcSEcCtD
Nortriptyline—Dermatitis—Valsartan—type 2 diabetes mellitus	5.69e-05	0.000474	CcSEcCtD
Nortriptyline—Vomiting—Orlistat—type 2 diabetes mellitus	5.68e-05	0.000473	CcSEcCtD
Nortriptyline—Insomnia—Ramipril—type 2 diabetes mellitus	5.67e-05	0.000472	CcSEcCtD
Nortriptyline—Headache—Valsartan—type 2 diabetes mellitus	5.66e-05	0.000471	CcSEcCtD
Nortriptyline—Diarrhoea—Metformin—type 2 diabetes mellitus	5.63e-05	0.000469	CcSEcCtD
Nortriptyline—Rash—Orlistat—type 2 diabetes mellitus	5.63e-05	0.000469	CcSEcCtD
Nortriptyline—Paraesthesia—Ramipril—type 2 diabetes mellitus	5.62e-05	0.000469	CcSEcCtD
Nortriptyline—Dermatitis—Orlistat—type 2 diabetes mellitus	5.62e-05	0.000468	CcSEcCtD
Nortriptyline—Headache—Orlistat—type 2 diabetes mellitus	5.59e-05	0.000466	CcSEcCtD
Nortriptyline—Asthenia—Irbesartan—type 2 diabetes mellitus	5.57e-05	0.000464	CcSEcCtD
Nortriptyline—Somnolence—Ramipril—type 2 diabetes mellitus	5.57e-05	0.000464	CcSEcCtD
Nortriptyline—Oxcarbazepine—ALB—type 2 diabetes mellitus	5.55e-05	0.0204	CrCbGaD
Nortriptyline—Clomipramine—CYP1A2—type 2 diabetes mellitus	5.52e-05	0.0203	CrCbGaD
Nortriptyline—Dyspepsia—Ramipril—type 2 diabetes mellitus	5.51e-05	0.000459	CcSEcCtD
Nortriptyline—Pruritus—Irbesartan—type 2 diabetes mellitus	5.49e-05	0.000458	CcSEcCtD
Nortriptyline—Decreased appetite—Ramipril—type 2 diabetes mellitus	5.45e-05	0.000454	CcSEcCtD
Nortriptyline—Dizziness—Metformin—type 2 diabetes mellitus	5.44e-05	0.000453	CcSEcCtD
Nortriptyline—Fatigue—Ramipril—type 2 diabetes mellitus	5.4e-05	0.00045	CcSEcCtD
Nortriptyline—Amitriptyline—ADRA2A—type 2 diabetes mellitus	5.39e-05	0.0198	CrCbGaD
Nortriptyline—Hypersensitivity—Losartan—type 2 diabetes mellitus	5.38e-05	0.000448	CcSEcCtD
Nortriptyline—Nausea—Valsartan—type 2 diabetes mellitus	5.37e-05	0.000447	CcSEcCtD
Nortriptyline—Constipation—Ramipril—type 2 diabetes mellitus	5.36e-05	0.000446	CcSEcCtD
Nortriptyline—Diarrhoea—Irbesartan—type 2 diabetes mellitus	5.31e-05	0.000443	CcSEcCtD
Nortriptyline—Nausea—Orlistat—type 2 diabetes mellitus	5.3e-05	0.000442	CcSEcCtD
Nortriptyline—Asthenia—Losartan—type 2 diabetes mellitus	5.24e-05	0.000437	CcSEcCtD
Nortriptyline—Vomiting—Metformin—type 2 diabetes mellitus	5.23e-05	0.000436	CcSEcCtD
Nortriptyline—Rash—Metformin—type 2 diabetes mellitus	5.19e-05	0.000432	CcSEcCtD
Nortriptyline—Dermatitis—Metformin—type 2 diabetes mellitus	5.18e-05	0.000432	CcSEcCtD
Nortriptyline—Pruritus—Losartan—type 2 diabetes mellitus	5.17e-05	0.000431	CcSEcCtD
Nortriptyline—Feeling abnormal—Ramipril—type 2 diabetes mellitus	5.16e-05	0.00043	CcSEcCtD
Nortriptyline—Headache—Metformin—type 2 diabetes mellitus	5.15e-05	0.000429	CcSEcCtD
Nortriptyline—Dizziness—Irbesartan—type 2 diabetes mellitus	5.13e-05	0.000428	CcSEcCtD
Nortriptyline—Diarrhoea—Losartan—type 2 diabetes mellitus	5e-05	0.000416	CcSEcCtD
Nortriptyline—Imipramine—HTR2C—type 2 diabetes mellitus	4.99e-05	0.0184	CrCbGaD
Nortriptyline—Urticaria—Ramipril—type 2 diabetes mellitus	4.98e-05	0.000415	CcSEcCtD
Nortriptyline—Amitriptyline—HTR2C—type 2 diabetes mellitus	4.96e-05	0.0183	CrCbGaD
Nortriptyline—Body temperature increased—Ramipril—type 2 diabetes mellitus	4.95e-05	0.000413	CcSEcCtD
Nortriptyline—Abdominal pain—Ramipril—type 2 diabetes mellitus	4.95e-05	0.000413	CcSEcCtD
Nortriptyline—Vomiting—Irbesartan—type 2 diabetes mellitus	4.94e-05	0.000411	CcSEcCtD
Nortriptyline—Rash—Irbesartan—type 2 diabetes mellitus	4.89e-05	0.000408	CcSEcCtD
Nortriptyline—Dermatitis—Irbesartan—type 2 diabetes mellitus	4.89e-05	0.000407	CcSEcCtD
Nortriptyline—Nausea—Metformin—type 2 diabetes mellitus	4.89e-05	0.000407	CcSEcCtD
Nortriptyline—Headache—Irbesartan—type 2 diabetes mellitus	4.86e-05	0.000405	CcSEcCtD
Nortriptyline—Doxepin—CYP1A2—type 2 diabetes mellitus	4.84e-05	0.0178	CrCbGaD
Nortriptyline—Dizziness—Losartan—type 2 diabetes mellitus	4.83e-05	0.000402	CcSEcCtD
Nortriptyline—Desipramine—CYP2E1—type 2 diabetes mellitus	4.67e-05	0.0172	CrCbGaD
Nortriptyline—Vomiting—Losartan—type 2 diabetes mellitus	4.64e-05	0.000387	CcSEcCtD
Nortriptyline—Hypersensitivity—Ramipril—type 2 diabetes mellitus	4.62e-05	0.000385	CcSEcCtD
Nortriptyline—Nausea—Irbesartan—type 2 diabetes mellitus	4.61e-05	0.000384	CcSEcCtD
Nortriptyline—Rash—Losartan—type 2 diabetes mellitus	4.61e-05	0.000384	CcSEcCtD
Nortriptyline—Dermatitis—Losartan—type 2 diabetes mellitus	4.6e-05	0.000383	CcSEcCtD
Nortriptyline—Headache—Losartan—type 2 diabetes mellitus	4.58e-05	0.000381	CcSEcCtD
Nortriptyline—Asthenia—Ramipril—type 2 diabetes mellitus	4.49e-05	0.000374	CcSEcCtD
Nortriptyline—Desipramine—CYP1A2—type 2 diabetes mellitus	4.44e-05	0.0164	CrCbGaD
Nortriptyline—Pruritus—Ramipril—type 2 diabetes mellitus	4.43e-05	0.000369	CcSEcCtD
Nortriptyline—Nausea—Losartan—type 2 diabetes mellitus	4.34e-05	0.000362	CcSEcCtD
Nortriptyline—Diarrhoea—Ramipril—type 2 diabetes mellitus	4.29e-05	0.000357	CcSEcCtD
Nortriptyline—Dizziness—Ramipril—type 2 diabetes mellitus	4.14e-05	0.000345	CcSEcCtD
Nortriptyline—Atomoxetine—CYP3A4—type 2 diabetes mellitus	4.09e-05	0.0151	CrCbGaD
Nortriptyline—Mianserin—CYP3A4—type 2 diabetes mellitus	3.99e-05	0.0147	CrCbGaD
Nortriptyline—Vomiting—Ramipril—type 2 diabetes mellitus	3.98e-05	0.000332	CcSEcCtD
Nortriptyline—Imipramine—CYP2E1—type 2 diabetes mellitus	3.96e-05	0.0146	CrCbGaD
Nortriptyline—Rash—Ramipril—type 2 diabetes mellitus	3.95e-05	0.000329	CcSEcCtD
Nortriptyline—Dermatitis—Ramipril—type 2 diabetes mellitus	3.95e-05	0.000329	CcSEcCtD
Nortriptyline—Amitriptyline—CYP2E1—type 2 diabetes mellitus	3.93e-05	0.0145	CrCbGaD
Nortriptyline—Headache—Ramipril—type 2 diabetes mellitus	3.92e-05	0.000327	CcSEcCtD
Nortriptyline—Imipramine—CYP1A2—type 2 diabetes mellitus	3.76e-05	0.0139	CrCbGaD
Nortriptyline—Amitriptyline—CYP1A2—type 2 diabetes mellitus	3.74e-05	0.0138	CrCbGaD
Nortriptyline—Nausea—Ramipril—type 2 diabetes mellitus	3.72e-05	0.00031	CcSEcCtD
Nortriptyline—Clomipramine—CYP3A4—type 2 diabetes mellitus	3.65e-05	0.0135	CrCbGaD
Nortriptyline—Trimipramine—CYP3A4—type 2 diabetes mellitus	3.36e-05	0.0124	CrCbGaD
Nortriptyline—Doxepin—CYP3A4—type 2 diabetes mellitus	3.2e-05	0.0118	CrCbGaD
Nortriptyline—Clomipramine—ALB—type 2 diabetes mellitus	3.19e-05	0.0117	CrCbGaD
Nortriptyline—Desipramine—CYP3A4—type 2 diabetes mellitus	2.94e-05	0.0108	CrCbGaD
Nortriptyline—Imipramine—CYP3A4—type 2 diabetes mellitus	2.49e-05	0.00918	CrCbGaD
Nortriptyline—Amitriptyline—CYP3A4—type 2 diabetes mellitus	2.48e-05	0.00913	CrCbGaD
Nortriptyline—Amitriptyline—ALB—type 2 diabetes mellitus	2.16e-05	0.00796	CrCbGaD
Nortriptyline—HTR2A—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.31e-06	1.52e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.3e-06	1.52e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—NOS3—type 2 diabetes mellitus	1.3e-06	1.52e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—PPARG—type 2 diabetes mellitus	1.3e-06	1.51e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.3e-06	1.51e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.3e-06	1.51e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	1.3e-06	1.51e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—PIK3R1—type 2 diabetes mellitus	1.3e-06	1.51e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—NOS3—type 2 diabetes mellitus	1.3e-06	1.51e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.3e-06	1.51e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.3e-06	1.51e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	1.3e-06	1.51e-05	CbGpPWpGaD
Nortriptyline—HTR1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.29e-06	1.51e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.29e-06	1.5e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.29e-06	1.5e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	1.29e-06	1.5e-05	CbGpPWpGaD
Nortriptyline—HTR2C—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.29e-06	1.5e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.28e-06	1.49e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—SRC—type 2 diabetes mellitus	1.28e-06	1.49e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.28e-06	1.49e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.28e-06	1.49e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	1.28e-06	1.49e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	1.28e-06	1.49e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—INS—type 2 diabetes mellitus	1.28e-06	1.49e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.28e-06	1.49e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.28e-06	1.49e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.28e-06	1.48e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.27e-06	1.48e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.27e-06	1.48e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	1.27e-06	1.48e-05	CbGpPWpGaD
Nortriptyline—ALB—Hemostasis—AKT1—type 2 diabetes mellitus	1.27e-06	1.48e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.27e-06	1.47e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	1.26e-06	1.47e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	1.25e-06	1.45e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.25e-06	1.45e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—RELA—type 2 diabetes mellitus	1.25e-06	1.45e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	1.25e-06	1.45e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.25e-06	1.45e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	1.24e-06	1.44e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	1.24e-06	1.44e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.23e-06	1.43e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	1.23e-06	1.43e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—RELA—type 2 diabetes mellitus	1.23e-06	1.43e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	1.23e-06	1.43e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	1.23e-06	1.43e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—RELA—type 2 diabetes mellitus	1.23e-06	1.43e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	1.22e-06	1.42e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	1.22e-06	1.42e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—RELA—type 2 diabetes mellitus	1.22e-06	1.42e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.22e-06	1.42e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	1.22e-06	1.42e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.22e-06	1.42e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—RELA—type 2 diabetes mellitus	1.22e-06	1.42e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	1.22e-06	1.42e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.21e-06	1.41e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.21e-06	1.41e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	1.21e-06	1.41e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—RELA—type 2 diabetes mellitus	1.21e-06	1.4e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.21e-06	1.4e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—RELA—type 2 diabetes mellitus	1.2e-06	1.4e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.2e-06	1.39e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.2e-06	1.39e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.19e-06	1.39e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—PTGS2—type 2 diabetes mellitus	1.19e-06	1.39e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—PTGS2—type 2 diabetes mellitus	1.19e-06	1.38e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	1.19e-06	1.38e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.18e-06	1.37e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	1.17e-06	1.36e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	1.17e-06	1.36e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.17e-06	1.36e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.15e-06	1.34e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	1.15e-06	1.33e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.15e-06	1.33e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.14e-06	1.33e-05	CbGpPWpGaD
Nortriptyline—DRD2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.14e-06	1.32e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.13e-06	1.31e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	1.12e-06	1.31e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.12e-06	1.31e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—PIK3R1—type 2 diabetes mellitus	1.12e-06	1.3e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—NOS3—type 2 diabetes mellitus	1.12e-06	1.3e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.12e-06	1.3e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.12e-06	1.3e-05	CbGpPWpGaD
Nortriptyline—HTR2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.12e-06	1.3e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—SRC—type 2 diabetes mellitus	1.12e-06	1.3e-05	CbGpPWpGaD
Nortriptyline—HRH1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.12e-06	1.3e-05	CbGpPWpGaD
Nortriptyline—CHRM1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.11e-06	1.29e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—SRC—type 2 diabetes mellitus	1.11e-06	1.29e-05	CbGpPWpGaD
Nortriptyline—CHRM3—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.11e-06	1.29e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.11e-06	1.29e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.11e-06	1.29e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	1.1e-06	1.28e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.1e-06	1.28e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.1e-06	1.28e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.1e-06	1.28e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.1e-06	1.28e-05	CbGpPWpGaD
Nortriptyline—CHRM2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.1e-06	1.28e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.1e-06	1.27e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.1e-06	1.27e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.09e-06	1.27e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.09e-06	1.27e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.09e-06	1.26e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.09e-06	1.26e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.08e-06	1.26e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.08e-06	1.26e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.08e-06	1.25e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	1.08e-06	1.25e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	1.07e-06	1.24e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	1.07e-06	1.24e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—SRC—type 2 diabetes mellitus	1.06e-06	1.24e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.06e-06	1.24e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.06e-06	1.23e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	1.06e-06	1.23e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	1.06e-06	1.23e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	1.05e-06	1.22e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.05e-06	1.22e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	1.05e-06	1.22e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	1.05e-06	1.22e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.05e-06	1.22e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	1.05e-06	1.22e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	1.05e-06	1.22e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.05e-06	1.21e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.04e-06	1.21e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	1.04e-06	1.21e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.04e-06	1.21e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.04e-06	1.21e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.04e-06	1.2e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	1.03e-06	1.2e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.03e-06	1.2e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.03e-06	1.2e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.03e-06	1.2e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.03e-06	1.2e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.03e-06	1.19e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.03e-06	1.19e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—PTGS2—type 2 diabetes mellitus	1.03e-06	1.19e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.02e-06	1.18e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—IL6—type 2 diabetes mellitus	1.02e-06	1.18e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.02e-06	1.18e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.01e-06	1.18e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.01e-06	1.18e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.01e-06	1.17e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	1.01e-06	1.17e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.01e-06	1.17e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	1.01e-06	1.17e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	1.01e-06	1.17e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	9.99e-07	1.16e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	9.97e-07	1.16e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	9.95e-07	1.16e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—TGFB1—type 2 diabetes mellitus	9.94e-07	1.16e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	9.82e-07	1.14e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—SRC—type 2 diabetes mellitus	9.81e-07	1.14e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.8e-07	1.14e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.75e-07	1.13e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	9.68e-07	1.12e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—SRC—type 2 diabetes mellitus	9.66e-07	1.12e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	9.64e-07	1.12e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—SRC—type 2 diabetes mellitus	9.64e-07	1.12e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—SRC—type 2 diabetes mellitus	9.6e-07	1.12e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—IL6—type 2 diabetes mellitus	9.59e-07	1.12e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	9.59e-07	1.12e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—SRC—type 2 diabetes mellitus	9.57e-07	1.11e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	9.56e-07	1.11e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	9.52e-07	1.11e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—SRC—type 2 diabetes mellitus	9.48e-07	1.1e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—SRC—type 2 diabetes mellitus	9.45e-07	1.1e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	9.43e-07	1.1e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	9.4e-07	1.09e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	9.4e-07	1.09e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	9.38e-07	1.09e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—AKT1—type 2 diabetes mellitus	9.38e-07	1.09e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	9.35e-07	1.09e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.33e-07	1.08e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	9.32e-07	1.08e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	9.26e-07	1.08e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	9.26e-07	1.08e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	9.23e-07	1.07e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	9.21e-07	1.07e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	9.2e-07	1.07e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—IL6—type 2 diabetes mellitus	9.19e-07	1.07e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	9.18e-07	1.07e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	9.18e-07	1.07e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	9.16e-07	1.06e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	9.12e-07	1.06e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	9.04e-07	1.05e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	8.94e-07	1.04e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—AKT1—type 2 diabetes mellitus	8.85e-07	1.03e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.77e-07	1.02e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	8.68e-07	1.01e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—IL6—type 2 diabetes mellitus	8.64e-07	1e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.63e-07	1e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.61e-07	1e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.6e-07	1e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.59e-07	9.98e-06	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.56e-07	9.95e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	8.51e-07	9.89e-06	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—AKT1—type 2 diabetes mellitus	8.48e-07	9.85e-06	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.48e-07	9.85e-06	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	8.46e-07	9.84e-06	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.46e-07	9.84e-06	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.45e-07	9.83e-06	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.45e-07	9.82e-06	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.42e-07	9.79e-06	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	8.39e-07	9.75e-06	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.39e-07	9.75e-06	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.31e-07	9.66e-06	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.29e-07	9.63e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	8.24e-07	9.58e-06	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	8.2e-07	9.53e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	8.11e-07	9.42e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	8.08e-07	9.39e-06	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—AKT1—type 2 diabetes mellitus	8.02e-07	9.33e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	7.98e-07	9.28e-06	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.97e-07	9.26e-06	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	7.84e-07	9.11e-06	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	7.84e-07	9.11e-06	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—IL6—type 2 diabetes mellitus	7.53e-07	8.75e-06	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—IL6—type 2 diabetes mellitus	7.49e-07	8.71e-06	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	7.17e-07	8.34e-06	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—IL6—type 2 diabetes mellitus	7.17e-07	8.34e-06	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—AKT1—type 2 diabetes mellitus	7.12e-07	8.27e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	7.04e-07	8.18e-06	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.95e-07	8.07e-06	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.91e-07	8.03e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	6.9e-07	8.02e-06	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.61e-07	7.69e-06	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—IL6—type 2 diabetes mellitus	6.61e-07	7.68e-06	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—IL6—type 2 diabetes mellitus	6.5e-07	7.56e-06	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—IL6—type 2 diabetes mellitus	6.49e-07	7.54e-06	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—IL6—type 2 diabetes mellitus	6.47e-07	7.52e-06	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—IL6—type 2 diabetes mellitus	6.45e-07	7.5e-06	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—IL6—type 2 diabetes mellitus	6.39e-07	7.42e-06	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—IL6—type 2 diabetes mellitus	6.37e-07	7.4e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	6.33e-07	7.35e-06	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.1e-07	7.09e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	6.05e-07	7.03e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	6.05e-07	7.03e-06	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	6e-07	6.98e-06	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—AKT1—type 2 diabetes mellitus	6e-07	6.97e-06	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.99e-07	6.96e-06	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—AKT1—type 2 diabetes mellitus	5.98e-07	6.95e-06	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.97e-07	6.94e-06	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.95e-07	6.92e-06	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.89e-07	6.85e-06	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.88e-07	6.83e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	5.53e-07	6.43e-06	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—AKT1—type 2 diabetes mellitus	5.15e-07	5.99e-06	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	4.63e-07	5.38e-06	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	4.25e-07	4.95e-06	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	4.22e-07	4.9e-06	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	3.6e-07	4.19e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	2.78e-07	3.23e-06	CbGpPWpGaD
